
Pharmacally
Disease & Drugs
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Disease & Drugs
Clinical TrialsNovo Nordisk’s Wegovy (Semaglutide) Reduces Cardiovascular Event Risk Compared With Tirzepatide: Findings from the STEER Real-World Study, ESC 2025At European Society of Cardiology Congress 2025 in Madrid happening between August 29 to 1 September 2025, Novo Nordisk reported that Wegovy (semaglutide 2.4 mg) was linked to…Fact-Checked
Research“Ginkgo Biloba as a Thrombolytic Agent: Can It Replace Aspirin in Long-Term Therapy?”Final Review and Fact-Check By: Ayurvedacharya Dr. Gaurav Pathare, BAMS…Fact-Checked
New Drug ApprovalPatients Gain a New Way to Continue Alzheimer’s Treatment as FDA Authorizes Eisai-Biogen’s LEQEMBI IQLIKIn a major step, the U.S. Food and Drug Administration (FDA) has approved LEQEMBI® IQLIK™ (lecanemab-irmb) as a subcutaneous injection for maintenance dosing in patients with early Alzheimer’s…Fact-Checked
ResearchShingles Vaccine May Protect the Heart for Up to Eight Years, Landmark South Korean Study FindsShingles are also called herpes zoster, is a painful skin rash caused by the reactivation of the chickenpox virus in later phase of life.Fact-Checked
ResearchTaiwan Study: Heatwaves Age People Like Smoking or AlcoholDr. Swati Deore-Pawar, Cosmetologist (BAMS, ACCR, PGDCC)…Fact-Checked
Drugs Safety AlertFDA Suspends Valneva’s Ixchiq Chikungunya Vaccine License after Deaths and Severe Adverse Events: Complete Safety TimelineOn August 22, 2025, the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) suspended the biologics license for Valneva Austria GmbH’s live-attenuated chikungunya vaccine…Fact-Checked
New Drug Approval“FDA Gives Nod to Lynozyfic, Bringing New Hope for Relapsed or Refractory Multiple Myeloma”“Lynozyfic (Linvoseltamab-gcpt) is a bispecific BCMA-directed CD3 T-cell engager. On July 2, 2025, the U.S.Fact-Checked
Drugs Safety Alert“FDA Launches Daily Adverse Event Reporting via FAERS: What You Need to Know”On August 22, 2025, the FDA rolled out daily updates of adverse event data via its FDA Adverse Event Reporting System (FAERS), replacing the slower quarterly updates.Fact-Checked
New Drug Approval“FDA Approval of VIZZ Brings Hope for Presbyopia Patients”LENZ Therapeutics received a FDA approval for VIZZ. VIZZ is preservative free aceclidine ophthalmologic solution which the first and one and only FDA approved aceclidine based eye-drop for…Fact-Checked
Drugs Safety AlertFDA Officials Raise Concerns with New Class Safety Warning on mRNA COVID-19 VaccinesThe U.S. Food and Drug Administration (FDA) has issued a class-wide safety labelling change for mRNA COVID-19 vaccines, mentioning persistent and potentially worsening cardiac effects in young males…Fact-Checked
Clinical TrialsFDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after Third Death from Liver Failure19 July 2025 Category: Drug Safety Alert / Gene Therapy Safety Update Written by: Pharmacally Medical News Desk Sarepta Therapeutics…Fact-Checked
Research“Repurposing Fenbendazole in Oncology: Hype vs. Hope in the Context of the ‘Joe Tippens Protocol’”photo by kjpargeter from Freepik.com At a Glance Fenbendazole is an animal dewormer with no regulatory approval for human use.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.